ID: MRFR/MED/5473-HCR | February 2021 | Region: Global | 130 pages
Market Scenario:
Global Coronary Stents Market is expected to grow significantly over the forecast period. The market held a market value of USD 9,382.63 Million in 2017 and is projected to grow at a CAGR of 7.81% over the forecast period.
Coronary stents are used in the process of angioplasty to make the cross-section of the blood vessel wider. Stents hold the walls of the vessel and thus do not let it sag or shrink, thereby curing the blockages in the vessel. Coronary stents have substantially changed the practice of interventional cardiology by reducing early complications such as abrupt vessel closure and improving late clinical outcome (restenosis). This results in patient and physician satisfaction. Thus, this factor contributes heavily to the growth of this market.
Moreover, the wide acceptance of prosthesis in coronary artery treatment procedures also fuels the market growth. Key companies are also engaged in new product launches related to coronary stents owing to the wide acceptance of the product. For instance, in May 2018, Terumo Europe NV announced the launch of Ultimaster Tansei drug eluting stent in Europe.
The market, by coronary stents, is further segmented into drug eluting stents, bare metal stents, and bioresorbable vascular scaffolds. Drug-eluting stents are metal stents that have been coated with a pharmacologic drug known to suppress restenosis, whereas bare metal stents are stents without a covering or a coating. Bioresorbable vascular scaffolds are intended to provide mechanical support and drug delivery similar to drug eluting stents, followed by complete resorption in some years.
Segmentation:
Global Coronary Stents Market has been segmented into products, and end user.Based on products, the market has been segmented into, Drug Eluting Stents, Bare Metal Stents, and Bioresorbable Vascular Scaffolds. The drug eluting stent segment is expected to account for the largest share in the global coronary stents market in 2017. This large share is majorly attributed to the wider acceptance of the drug eluting stents in the angioplasty procedures, better patient compliance as compared to the bare metal stents. On the other hand, bioresorbable stents are projected to grow at the fastest rate during the forecast period.
On the basis of end users, the market has been segmented into hospitals & clinics, ambulatory surgical centres, specialty centres, and others. The hospitals & clinics segment is expected to account for the largest share in the global coronary stents market in 2017. At the same time, the increasing establishments of the ambulatory surgical centres in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.Based on the regions, the market for coronary stents is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The coronary stents market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.
European Coronary Stents Market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Coronary Stents Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The coronary stents market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical, Elixir Medical Corporation, Medtronic plc, Meril Life Sciences, MicroPort Scientific Corporation, Stentys SA, and Terumo Corporation are some of the key players in the global coronary stents market.
Regional Market Summary
Global Coronary stents market Share (%), by Region, 2017
Source: White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the global coronary stents market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial blockage, and coronary artery disease among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way. According to the data published by the Department of Health, New York in May 2018, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. Besides this, the high medical awareness among American population, high disposable income, presence of the top medical device manufacturers in the region are some of the many factors that drive the growth of the coronary stents market in this region.
Europe is expected to hold the second largest market share in the global coronary stents market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the coronary stents market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the coronary stents market during the forecast period.
Global Coronary Stents Market, by Products:
Global Coronary Stents Market, by End User:
Global Coronary Stents Market, by Region:
Global Coronary stents market, by Key Players:
Intended Audience:
Frequently Asked Questions (FAQ) :
Coronary Stents Market valuation in 2017 was USD 9, 382.63 million.
The Coronary Stents Market has the cope to move forward with 7.81% CAGR during the forecast period of 2018 to 2023.
The hospitals & clinics segment has the opportunity to lead the global Coronary Stents Market.
The drug-eluting stent market has a maximum Coronary Stents Market share.
The Americas has a better Coronary Stents Market share.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Coronary Stents Market, by Products
6.1 Introduction
6.2 Drug Eluting Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Bare Metal Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Bioresorbable Vascular Scaffolds
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Coronary Stents Market, By End-User
7.1 Introduction
7.2 Hospitals and Clinics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Specialty Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Coronary Stents Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Abbott
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Biotronik SE & Co. KG
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 C. R. Bard, Inc.
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Cook Medical
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Elixir Medical Corporation
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Medtronic plc
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Meril Life Sciences
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 MicroPort Scientific Corporation
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Stentys SA
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.10 Terumo Corporation
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s View point
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the Coronary Stents Market Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Coronary Stents Market Synopsis, 2020-2027
Table 2 Global Coronary Stents Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 4 Global Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 5 Global Coronary Stents Market, by Region, 2020-2027(USD Million)
Table 6 North America: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 7 North America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 8 North America: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 9 US: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 10 US: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 11 US: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 12 Canada: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 13 Canada: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 14 Canada: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 15 South America: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 16 South America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 17 South America: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 18 Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 19 Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 20 Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 21 Western Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 22 Western Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 23 Western Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 24 Eastern Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 25 Eastern Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 26 Eastern Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 27 Asia-Pacific: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 28 Asia-Pacific: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 29 Asia-Pacific: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 30 Middle East & Africa: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 31 Middle East & Africa: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 32 Middle East & Africa: Coronary Stents Market, by Region, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Coronary Stents Market
Figure 3 Segmentation Market Dynamics for Global Coronary Stents Market
Figure 4 Global Coronary Stents Market Share, by Product, 2020 (%)
Figure 5 Global Coronary Stents Market Share, by End-User, 2020 (%)
Figure 6 Global Coronary Stents Market Share, by Region, 2020 (%)
Figure 7 North America: Coronary Stents Market Share, by Country, 2020 (%)
Figure 8 Europe: Coronary Stents Market Share, by Country, 2020 (%)
Figure 9 Asia-Pacific: Coronary Stents Market Share, by Country, 2020 (%)
Figure 10 Middle East & Africa: Coronary Stents Market Share, by Country, 2020 (%)
Figure 11 Global Coronary Stents Market: Company Share Analysis, 2020 (%)
Figure 12 Abbott: Key Financials
Figure 13 Abbott: Segmental Revenue
Figure 14 Abbott: Geographical Revenue
Figure 15 B. Braun Melsungen AG: Key Financials
Figure 16 B. Braun Melsungen AG: Segmental Revenue
Figure 17 B. Braun Melsungen AG: Geographical Revenue
Figure 18 Biotronik SE & Co. KG: Key Financials
Figure 19 Biotronik SE & Co. KG: Segmental Revenue
Figure 20 Biotronik SE & Co. KG: Geographical Revenue
Figure 21 Boston Scientific Corporation: Key Financials
Figure 22 Boston Scientific Corporation: Segmental Revenue
Figure 23 Boston Scientific Corporation: Geographical Revenue
Figure 24 C. R. BARD, INC.: Key Financials
Figure 25 C. R. BARD, INC.: Segmental Revenue
Figure 26 C. R. BARD, INC.: Geographical Revenue
Figure 27 Cook Medical: Key Financials
Figure 28 Cook Medical: Segmental Revenue
Figure 29 Cook Medical: Geographical Revenue
Figure 30 Elixir Medical Corporation: Key Financials
Figure 31 Elixir Medical Corporation: Segmental Revenue
Figure 32 Elixir Medical Corporation: Geographical Revenue
Figure 33 Medtronic plc: Key Financials
Figure 34 Medtronic plc: Segmental Revenue
Figure 35 Medtronic plc: Geographical Revenue
Figure 36 Meril Life Sciences: Key Financials
Figure 37 Meril Life Sciences: Segmental Revenue
Figure 38 Meril Life Sciences: Geographical Revenue
Figure 39 MicroPort Scientific Corporation: Key Financials
Figure 40 MicroPort Scientific Corporation: Segmental Revenue
Figure 41 MicroPort Scientific Corporation: Geographical Revenue
Figure 42 Stentys SA: Key Financials
Figure 43 Stentys SA: Segmental Revenue
Figure 44 Stentys SA: Geographical Revenue
Figure 45 Terumo Corporation: Key Financials
Figure 46 Terumo Corporation: Segmental Revenue
Figure 47 Terumo Corporation: Geographical Revenue